Lower Prices for Wegovy and Ozempic — Will You Pay Less?
Novo Nordisk has announced plans to lower the U.S. list prices of Wegovy, Ozempic, and the oral GLP-1 medicine Rybelsus to $675 per month beginning January 1, 2027 — a […]
Lower Prices for Wegovy and Ozempic — Will You Pay Less? Read More »
